Dean Messing

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Pfizer (United States)21.9%
• Bristol-Myers Squibb (United States)15.7%
• Biogen (United States)7.2%
• Principia Biopharma (United States)6.7%
• Harvard University6.4%
• Tianjin Medical University General Hospital5.7%
• Other36.3%

Fields

• Medicine64.6%
• Biochemistry, Genetics and Molecular Biology12.2%
• Immunology and Microbiology8.5%
• Pharmacology, Toxicology and Pharmaceutics8.5%
• Computer Science3.7%
• Chemistry1.2%
• Other1.2%

Topics

• Chronic Lymphocytic Leukemia Research20.8%
• Monoclonal and Polyclonal Antibodies Research9.7%
• Lymphoma Diagnosis and Treatment9%
• Systemic Lupus Erythematosus Research7.6%
• Computational Drug Discovery Methods6.9%
• Pharmacogenetics and Drug Metabolism6.9%
• Other38.9%